# US 2026/0207811 A1 · Matrices for wound healing

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0207811 A1
- Document ID: US20260207811A1
- Status: Published application
- Kind: A1
- Application number: 19/134,787
- Filed: 2023-11-30
- Published: 2026-07-23
- Earliest claimed: 2022-12-02
- Assignees: Regenics AS
- Applicants: Regenics AS
- Inventors: Karin Gilljam; Henrik Lund
- Web page: https://patentgrep.com/patent/US20260207811A1

## CPC

- A61L 15/40: containing ingredients of undetermined constitution or reaction products thereof {, e.g. plant or animal extracts}
- A61L 15/20: containing organic materials
- A61L 15/225: {Mixtures of macromolecular compounds}
- A61L 15/42: Use of materials characterised by their function or physical properties (liquid bandages A61L26/00)
- A61L 15/44: Medicaments
- A61L 15/60: Liquid-swellable gel-forming materials, e.g. super-absorbents
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- B33Y 70/00: Materials specially adapted for additive manufacturing
- B33Y 80/00: Products made by additive manufacturing
- C08L 5/04: Alginic acid; Derivatives thereof
- C08L 5/14: Hemicellulose; Derivatives thereof
- A61L 2300/30: Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention provides articles for the improved healing of wounds, preferably burn wounds. In some preferred embodiments, the article is a matrix formed from a mixture of two or more polysaccharides, the matrix comprising an active ingredient which is an extract from differentiable cells.

## Claims

### Claim 1

An article comprising a matrix formed from at least a first polysaccharide, said matrix further comprising a differentiable cell extract and wherein the first polysaccharide is from a source different from the differentiable cell extract.

### Claim 2 (depends on 1)

The article of claim 1, wherein the first polysaccharide is alginate.

### Claim 3 (depends on 2)

The article of claim 2, wherein the weight/weight percent of the alginate in the article is from 1.0% to 10.0%.

### Claim 4 (depends on 1, 2, 3)

The article of any one of claims 1 to 3, further comprising a second polysaccharide from a source different from the differentiable cell extract.

### Claim 5 (depends on 4)

The article of claim 4, wherein the second polysaccharide is nanocellulose.

### Claim 6 (depends on 5)

The article of claim 5, wherein the weight/weight percent of the nanocellulose in the article is from 1.0% to 10.0%.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The article of any one of claims 1 to 6, wherein the nanocellulose is supplemented with mannitol.

### Claim 8 (depends on 6)

The article of claim 6, wherein the weight/weight percent of the mannitol used to supplement the nanocellulose is from 1.0% to 10.0%.

### Claim 9 (depends on 1, 2, 3, 4, 5, 6, 7, 8)

The article of any one of claims 1 to 8, wherein the volume/weight percent of the differentiable cell extract in the article is from 5.0% to 20.0%.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The article of anyone of claims 1 to 9, wherein the differentiable cell extract is a fish egg extract.

### Claim 11 (depends on 10)

The article of claim 10, wherein the fish egg extract is a salmonid egg extract.

### Claim 12 (depends on 10, 11)

The article any one of claims 10 to 11, wherein the fish egg extract is an unfertilized egg extract.

### Claim 13 (depends on 10, 11, 12)

The article of any one of claims 10 to 12, wherein the fish egg extract is characterized in having one or more of properties (a) to (f):
a) from 10 to 500 mg/ml protein and most preferably from 50 to 200 mg/ml protein, in an aqueous solution;
b) from 0.1 to 10 mg/ml RNA;
c) from 0.1 to 10 mg/ml DNA;
d) from 0.1-10% lipids w/w
e) an osmolarity of from 200 to 600 mOsm, most preferably from 330 to 440 mOsm; and
f) a pH of from about 5.0 to 7.7.

### Claim 14 (depends on 13)

The article of claim 13, wherein the fish egg extract has properties: (a) and (b); (a) and (c); (a) and (d); (a) and (e); (a) and (f); (a), (b), and (c); (a), (b), and (d); (a), (b), and (e); (a), (b), and (f); (a), (c), and (d); (a), (c), and (e); (a), (c), and (f); (a), (d), and (e); (a), (d), and (f); (a), (b), (c), and (d); (a), (b), (c), and (e); (a), (b), (c), and (f); (a), (c), (d), and (e); (a), (c), (d), and (f); (a), (c), (e), and (f); (a), (b), (c), (d) and (e); (a), (b), (c), (d) and (f); (a), (c), (d), (e) and (f); or (a), (b), (c), (d), (e), and (f).

### Claim 15 (depends on 10, 11, 12, 13, 14)

The article any one of claims 10 to 14, wherein the fish egg extract is a heat-treated fish egg extract.

### Claim 16 (depends on 15)

The article of claim 15, wherein the heat-treated fish egg extract is prepared by heating the fish egg extract to from 90 to 100 degrees Celsius for from 1 to 30 minutes.

### Claim 17 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)

The article of any one of claims 1 to 16, wherein the first or the first and second polysaccharides are cross-linked.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The article of any one of claims 1 to 17, wherein the matrix is a gel matrix.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The article of any one of claims 1 to 18, wherein the matrix is formed in a grid pattern.

### Claim 20

An article comprising a matrix formed from alginate, said matrix further comprising a heat-treated Salmo salar egg extract, wherein the weight/weight percent of the alginate in the article is from 1.0% to 10.0% and the volume/weight percent of the heat-treated Salmo salar egg extract in the article is from 5.0% to 20.0%.

### Claim 21 (depends on 20)

The article of claim 20, further comprising nanocellulose.

### Claim 22 (depends on 21)

The article of claim 21, wherein the weight/weight percent of nanocellulose in the article is from 1.0% to 10.0%.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6)

The article of any one of claims 1 to 6, wherein the nanocellulose is supplemented with mannitol.

### Claim 24 (depends on 6)

The article of claim 6, wherein the weight/weight percent of the mannitol used to supplement the nanocellulose is from 1.0% to 10.0%.

### Claim 25 (depends on 20, 21, 22, 23, 24)

The article any one of claims 20 to 24, wherein the heat-treated Salmo salar egg extract is prepared from unfertilized eggs.

### Claim 26 (depends on 20, 21, 22, 23, 24, 25)

The article of any one of claims 20 to 25, wherein the heat-treated Salmo salar egg extract is characterized in having one or more of properties (a) to (f):
a) from 50 to 500 mg/ml protein and most preferably from 10 to 5000 mg/ml protein and most preferably from 50 to 200 mg/ml protein, in an aqueous solution;
b) from 0.1 to 10 mg/ml RNA;
c) from 0.1 to 10 mg/ml DNA;
d) from 0.1-10% lipids w/w
e) an osmolarity of from 200 to 600 mOsm, most preferably from 330 to 440 mOsm; and
f) a pH of from about 5.0 to 7.7.

### Claim 27 (depends on 26)

The article of claim 26, wherein the fish egg extract has properties: (a) and (b); (a) and (c); (a) and (d); (a) and (e); (a) and (f); (a), (b), and (c); (a), (b), and (d); (a), (b), and (e); (a), (b), and (f); (a), (c), and (d); (a), (c), and (e); (a), (c), and (f); (a), (d), and (e); (a), (d), and (f); (a), (b), (c), and (d); (a), (b), (c), and (e); (a), (b), (c), and (f); (a), (c), (d), and (e); (a), (c), (d), and (f); (a), (c), (e), and (f); (a), (b), (c), (d) and (e); (a), (b), (c), (d) and (f); (a), (c), (d), (e) and (f); or (a), (b), (c), (d), (e), and (f).

### Claim 28 (depends on 20, 21, 22, 23, 24, 25, 26, 27)

The article of any one of claims 20 to 27, wherein the heat-treated Salmo salar egg extract is prepared by heating the Salmo salar egg extract to from 90 to 100 degrees Celsius for from 1 to 30 minutes.

### Claim 29 (depends on 20, 21, 22, 23, 24, 25, 26, 27, 28)

The article of any one of claims 20 to 28, wherein the matrix is a cross-linked gel matrix.

### Claim 30 (depends on 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The article of any one of claims 20 to 29, wherein the matrix is formed in a grid pattern.

### Claim 31

A method of producing a wound healing article comprising:
forming an aqueous mixture of at least a first polysaccharide and a fish egg extract;
forming a matrix from the aqueous mixture to provide the wound healing article; and
wherein the at least a first polysaccharide is from a source different from the fish egg extract.

### Claim 32 (depends on 31)

The method of claim 31, further comprising the step of cross linking the matrix to provide the wound healing article.

### Claim 33 (depends on 31, 32)

The method of any one of claims 31 to 32, wherein the first polysaccharide is alginate.

### Claim 34 (depends on 33)

The method of claim 33, wherein the alginate is included in the mixture at a weight/weight percent of from 1.0% to 10.0%.

### Claim 35 (depends on 31, 32, 33, 34)

The method of any one of claims 31 to 34, further comprising including a second polysaccharide in the aqueous mixture, wherein the second polysaccharide is from a source different from the fish egg extract.

### Claim 36 (depends on 35)

The method of claim 35, wherein the second polysaccharide is nanocellulose.

### Claim 37 (depends on 36)

The method of claim 36, wherein the nanocellulose is included in the mixture at a weight/weight percent of from 1.0% to 10.0%.

### Claim 38 (depends on 31, 32, 33, 34, 35, 36, 37)

The method of any one of claims 31 to 37, wherein the fish egg extract is included in the mixture at a volume/weight percent of from 5.0% to 20.0%.

### Claim 39 (depends on 31, 32, 33, 34, 35, 36, 37, 38)

The method of any one of claims 31 to 38, wherein the fish egg extract is from unfertilized fish eggs.

### Claim 40 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39)

The method of any one of claims 31 to 39, wherein the fish egg extract is a Salmo salar egg extract.

### Claim 41 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The method of any one of claims 31 to 40, wherein the fish egg extract is a heat-treated fish egg extract.

### Claim 42 (depends on 41)

The method of claim 41, wherein the heat-treated fish egg extract is prepared by heating the fish egg extract to a temperature of from 90 to 100 degrees Celsius for from 1 to 30 minutes.

### Claim 43 (depends on 40, 41, 42)

The method of any one of claims 40 to 42, wherein the heat-treated Salmo salar egg extract is characterized is characterized in having one or more of properties (a) to (f):
a) from 10 to 500 mg/ml protein and most preferably from 50 to 200 mg/ml protein, in an aqueous solution;
b) from 0.1 to 10 mg/ml RNA;
c) from 0.1 to 10 mg/ml DNA;
d) from 0.1-10% lipids w/w
e) an osmolarity of from 200 to 60 mOsm, most preferably from 330 to 440 mOsm; and
f) a pH of from about 5.0 to 7.7.

### Claim 44 (depends on 43)

The method of claim 43, wherein the fish egg extract has properties: (a) and (b); (a) and (c); (a) and (d); (a) and (e); (a) and (f); (a), (b), and (c); (a), (b), and (d); (a), (b), and (e); (a), (b), and (f); (a), (c), and (d); (a), (c), and (e); (a), (c), and (f); (a), (d), and (e); (a), (d), and (f); (a), (b), (c), and (d); (a), (b), (c), and (e); (a), (b), (c), and (f); (a), (c), (d), and (e); (a), (c), (d), and (f); (a), (c), (e), and (f); (a), (b), (c), (d) and (e); (a), (b), (c), (d) and (f); (a), (c), (d), (e) and (f); or (a), (b), (c), (d), (e), and (f).

### Claim 45 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The method of any one of claims 31 to 44, wherein the nanocellulose is supplemented with mannitol.

### Claim 46 (depends on 45)

The method of claim 45, wherein the weight/weight percent of the mannitol used to supplement the nanocellulose is from 1.0% to 10.0%.

### Claim 47 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method of anyone of claims 31 to 46, wherein the aqueous mixture further comprises CaCl2).

### Claim 48 (depends on 47)

The method of claim 47, wherein the CaCl2) is included in the aqueous mixture at a concentration of from 0.01 to 0.1 M.

### Claim 49 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48)

The method of any one of claims 31 to 48, wherein the matrix is formed by printing the aqueous mixture onto a substrate.

### Claim 50 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48)

The method of any one of claims 31 to 48, wherein the matrix is formed by molding the aqueous mixture.

### Claim 51 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50)

The method of any one of claims 31 to 50, wherein the matrix is cross-linked by treating the matrix with a cross-linking solution comprising CaCl2) at a concentration of from 0.01 to 0.1 M.

### Claim 52 (depends on 51)

The method of claim 51, wherein the cross-linking solution further comprises a weight/weight percent of NaCl of from 0.5% to 1.5%.

### Claim 53 (depends on 51, 52)

The method of any one of claims 51 to 52, wherein the cross-linking solution further comprises the fish egg extract at a volume/weight percent of from 5.0% to 20.0%.

### Claim 54 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53)

The method of any one of claims 31 to 53, wherein the matrix is a gel.

### Claim 55 (depends on 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

A matrix made by the method of any one of claims 31 to 54.

### Claim 56 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 55)

Article of any one of claims 1 to 30 or matrix of claim 55 for use in treating a wound in a subject.

### Claim 57 (depends on 56)

Use of claim 56, wherein the wound is a burn wound.

### Claim 58 (depends on 56)

Use of claim 56, wherein the wound is a chronic wound.

### Claim 59 (depends on 56, 57, 58)

Use of any one of claims 56 to 58, wherein the article or solid matrix is topically applied to the wound.

### Claim 60 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 55)

Method of treating a wound in a subject in need thereof comprising applying an article of any one of claims 1 to 30 or solid matrix of claim 55 to the wound.

### Claim 61 (depends on 60)

Method of claim 60, wherein the wound is a burn wound.

### Claim 62 (depends on 60)

Method of claim 60, wherein the wound is a chronic wound.

### Claim 63 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 55)

Use of an article of any one of claims 1 to 30 or matrix of claim 55 to reduce reactive oxygen species in a subject in need thereof.

### Claim 64 (depends on 63)

Use of claim 63, wherein the subject has a wound and the matrix is applied to the wound.

### Claim 65 (depends on 64)

Use of claim 64, wherein the subject has skin inflammation and the matrix is applied to the site of skin inflammation.

### Claim 66

Use of a fish egg extract or formulation thereof to reduce reactive oxygen species in a subject in need thereof, wherein the fish egg extract is characterized in having one or more of properties (a) to (f):
a) from 50 to 500 mg/ml protein and most preferably from 10 to 5000 mg/ml protein and most preferably from 50 to 200 mg/ml protein, in an aqueous solution;
b) from 0.1 to 10 mg/ml RNA;
c) from 0.1 to 10 mg/ml DNA;
d) from 0.1-10% lipids w/w
e) an osmolarity of from 200 to 600 mOsm, most preferably from 330 to 440 mOsm; and
f) a pH of from about 5.0 to 7.7

### Claim 67 (depends on 66)

Use of claim 66, wherein the subject has a wound and the fish egg extract is applied to the wound.

### Claim 68 (depends on 66)

Use of claim 66, wherein the subject has skin inflammation and the fish egg extract is applied to the site of skin inflammation.

### Claim 69 (depends on 66, 67, 68)

Use of any one of claims 66 to 68, wherein the fish egg extract has properties: (a) and (b); (a) and (c); (a) and (d); (a) and (e); (a) and (f); (a), (b), and (c); (a), (b), and (d); (a), (b), and (e); (a), (b), and (f); (a), (c), and (d); (a), (c), and (e); (a), (c), and (f); (a), (d), and (e); (a), (d), and (f); (a), (b), (c), and (d); (a), (b), (c), and (e); (a), (b), (c), and (f); (a), (c), (d), and (e); (a), (c), (d), and (f); (a), (c), (e), and (f); (a), (b), (c), (d) and (e); (a), (b), (c), (d) and (f); (a), (c), (d), (e) and (f); or (a), (b), (c), (d), (e), and (f).

### Claim 70 (depends on 66, 67, 68, 69)

Use of any one of claims 66 to 69, wherein the fish egg extract is a heat-treated fish egg extract.

### Claim 71 (depends on 66, 67, 68, 69, 70)

Use of any one of claims 66 to 70, wherein the fish egg extract is a heat-treated fish egg extract.
